086820 — Bio Solution Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for Bio Solution Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7,744	11,802	10,102	12,462	12,889
Cost of Revenue
Gross Profit	4,300	7,608	5,927	8,062	8,161
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	11,074	13,374	15,390	17,603	22,967
Operating Profit	-3,330	-1,572	-5,289	-5,141	-10,078
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,800	-1,685	-8,087	-1,356	-11,928
Net Income After Taxes	-1,800	-1,685	-8,087	-1,356	-11,928
Net Income Before Extraordinary Items
Net Income	-1,800	-1,685	-8,087	-1,356	-11,928
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-1,800	-1,685	-8,087	-1,356	-11,928
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-75.3	-70.6	-336	-56.4	-290
Dividends per Share